Quality-by-Design (QbD): Techniques for Quality Risk Analysis and Management Over the Product Life Cycle

Chair(s):
Wu, H., FDA
Co-chair(s):
Schenck, L. R., Merck & Co. Inc.

As the FDA and the pharmaceutical industry work together to embrace the shift of pharmaceutical quality regulation towards Quality-by-Design (QbD), a significant effort was made in the aspect of introducing a risk-based approach to pharmaceutical quality paradigm. The session will feature both invited and submitted papers presenting real world case examples on quality risk management over the product life cycle. Talks providing case studies successful experiences, and lessons learned, and to discuss the benefits and challenges associated with applying risk management principles over the product life cycle in the pharmaceutical community are targeted.

Papers:
Topics: 

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing


Individuals

2010 Annual Meeting
AIChE Members $150.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $225.00
Comprehensive Quality by Design in Pharmaceutical Development and Manufacture only
AIChE Members $100.00
AIChE Food, Pharmaceutical & Bioengineering Division Members Free
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $150.00